Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study-Reference-Cited by-同舟云学术

Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study

Published:2013-12-18 Issue:1 Volume:27 Page:77-86
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Stoelben Susanne¹,Arns Wolfgang²,Renders Lutz³,Hummel Jürgen⁴,Mühlfeld Anja⁵,Stangl Manfred⁶,Fischereder Michael⁷,Gwinner Wilfried⁸,Suwelack Barbara⁹,Witzke Oliver¹⁰,Dürr Michael¹¹,Beelen Dietrich W.¹²,Michel Detlef¹³,Lischka Peter¹,Zimmermann Holger¹,Rübsamen-Schaeff Helga¹,Budde Klemens¹¹

Affiliation:

1. AiCuris GmbH & Co. KG; Wuppertal Germany

2. Transplantationszentrum; Kliniken der Stadt Köln; Klinikum Merheim Germany

3. Department of Nephrology; Klinikum Rechts der Isar; Technical University Munich; Munich Germany

4. PPD; Bellshill UK

5. Department of Nephrology and Clinical Immunology; University Clinic of the RWTH Aachen University; Aachen Germany

6. Chirurgische Klinik und Poliklinik der TU München; Klinikum rechts der Isar; München Germany

7. Schwerpunkt Nephrologie; Klinik und Poliklinik für Innere Medizin I - Campus Grosshadern; München Germany

8. Department of Nephrology; Medical School Hannover; Hannover Germany

9. Transplantationszentrum; Universitätsklinikum Münster; Münster Germany

10. Klinik für Nephrologie; Universitätsklinikum Essen; Essen Germany

11. Department of Nephrology; Charité Universitätsmedizin Berlin; Berlin Germany

12. Klinik für Knochenmarkstransplantation; Universitätsklinikum Essen; Essen Germany

13. Institut für Virologie; Universitätsklinikum Ulm; Ulm Germany

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12225/fullpdf

Reference26 articles.

1. CMV: prevention, Diagnosis and therapy;Kotton;Am J Transplant,2013

2. Cytomegalovirus;Griffiths;Curr Opin Infect Dis,2005

3. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments;Gandhi;Lancet Infect Dis,2004

4. New developments in the management of cytomegalovirus infection after solid organ transplantation;Eid;Drugs,2010

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refractory/Resistant Cytomegalovirus Infection in Transplant Recipients: An Update;Viruses;2024-07-05

2. Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant Recipients;Transplantation Proceedings;2024-03

3. Antiviral Agents: Letermovir;Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century;2024

4. Infection Control, Prophylaxis, and Vaccinations in Hematopoietic Cell Transplantation Recipients;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

5. Letermovir Rescue Therapy in Kidney Transplant Recipients with Refractory/Resistant CMV Disease;Journal of Clinical Medicine;2023-12-23